ShapeShapeauthorShapechevroncrossShapeShapeShapeGrouphamburgerhomeGroupmagnifyShapeShapeShaperssShape

Protection against salmonella species now available in 12 European countries

Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries.

10 July 2019, at 2:34pm

Pig farmers in 12 European countries will now be able to protect their herds against the growing problem of Salmonella Typhimurium. Ceva will launch Salmoporc in Austria, Belgium, Czech Republic, Denmark, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Slovak Republic, United Kingdom through the remainder of 2019.

Oral vaccination of a piglet with Salmoporc salmonella vaccine
Oral vaccination of a piglet with Salmoporc salmonella vaccine

Salmoporc has been used on German and Polish farms for over 15 years and has proved to be safe and effective in controlling salmonella. The live attenuated vaccine can be administered orally in piglets and via subcutaneous injection in sows.

“Salmonella in pigs is growing threat and an important zoonotic disease. According to the 2018 European Food Safety Authority (EFSA) report, salmonellosis is the second most reported zoonosis in Europe with over 90.000 cases reported in humans,” said company veterinarian Dr Rike Schmelz.

“Salmonella Typhimurium and monophasic Salmonella Typhimurium represented 17 percent of confirmed human cases in 2017 so constitutes a major risk to humans.”

Salmoporc is the latest in a line of a number of zoonotic disease vaccines from Ceva, which through its “Together, beyond animal health” vision is committed to protecting people by improving preventative medicine in animals.